Dr. Joad Eseddi, MD

Dr. Eseddi practices at Parkland Memorial Hospital in Dallas, Texas, part of Parkland Health.

Dr. Eseddi's NPI, 1881037877, was assigned on April 10, 2013. Dr. Eseddi's Texas license number on file is Q9837.

Dr. Eseddi's primary practice is Parkland Memorial Hospital, at 5200 Harry Hines Blvd, Dallas, TX 75235 in Dallas County. The practice phone is (214) 590-8000.

Dr. Eseddi's primary practice is Parkland Memorial Hospital in Dallas, Texas, part of Parkland Health. Dr. Eseddi is also affiliated with John Peter Smith Hospital. The medical group on file is University of Texas Southwestern Medical Center. Dmand AI also links Dr. Eseddi to 3 more hospitals, 3 medical groups, 2 group practices and clinics, 1 clinical lab, 1 physician office and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Eseddi practices, 10 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Eseddi's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Eseddi is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Eseddi's licenses on file in 6 states: Texas, South Carolina, California, Georgia, West Virginia and Michigan.

CMS data shows 83 Medicare services from Dr. Eseddi across 3 procedure codes in 2024, for 99 Medicare patients. Medicare paid $8,189 for them.

CMS counts 99 Medicare patients who saw Dr. Eseddi in 2024. The largest group is 65 to 74, with 55 patients. 75% of them have arthritis, and 75% have high blood pressure. 20% are also on Medicaid. Their average risk score is 1.95, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Eseddi's median patient age at 58, with 71% women.

In 2024, Dr. Eseddi wrote 272 Medicare Part D claims for 83 patients. 83% of them were for generic drugs. CMS names the drug for 156 of them, across 5 drugs with 11 or more claims each, at $2,615 in total drug cost. In 2023, CMS named 56 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Eseddi for performance year 2024, reported through an alternative payment model (APM). Dr. Eseddi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Eseddi as offering telehealth.

Dmand AI links 3 papers to Dr. Eseddi, published from 2023 to 2025. 2023 was the busiest year, with 2. Dr. Eseddi's most frequent co-authors are Puneet Bajaj, MD, Luigino Rolando Mateo Bernabela, MD and Lesley Megan Davila, MD.

CMS Open Payments shows 3 general payments to Dr. Eseddi from 3 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. GlaxoSmithKline, LLC. paid the most, $33.

Dr. Eseddi is a member of ACR.

Dr. Eseddi is in network with 20 carriers, including Aetna, Elevance and HCSC. HMO plans come from the most carriers, 10. Check the plan with the practice before a visit.